SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Tabletop particle accelerator could transform medicine and materials science 
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
Memory has long been one of the most elusive concepts in human history, largely because the brain can be unreliable in storing and recalling information. Now, findings indicate that higher levels of a chemical known as gamma-Aminobutyric acid or GABA in one particular part of the brain can result in better memory retention and recall.
Researchers from the Stanford University School of Medicine and University of California-Davis teamed up to look into the role that GABA plays in organizing and using multiple pieces of information at once. They found that the amount of the chemical present in a particular part of the brain has a huge impact on these factors, MedicalXpress reports.
This discovery has a tremendous impact on several memory aspects, including working memory. This is when a person is multitasking by talking to someone, cleaning the house, and trying to remember what they are supposed to do for the rest of the day at the same time.
Unfortunately, it’s a simple fact of life that working memory declines as the brain ages, and time isn’t even the only factor that makes it decay faster. Depending on lifestyle and habits, certain individuals could find that they are no longer able to tap into working memory as well as they used to.
Jong Yoon, MD from Stanford University is the lead author of the study. According to him, problems with working memory is particularly apparent among those with neurological problems.
"Deficits in working memory also characterize various neuropsychiatric conditions and are particularly evident in schizophrenia," Yoon said.
One of the ways that working memory decay can be slowed down is maintaining high levels of GABA in the part of the brain called dorsolateral prefrontal cortex. This part is incredibly important in allowing humans to plan, organize their tasks, and know what to prioritize.
In related news, GABA is also being considered as a component to help combat depression, Bioworld reports. Current antidepressant drugs contain chemicals that target serotonin in order to achieve balanced in the brain. However, glutamate and GABA also play a huge role in the chemical imbalance that the brains of depressed patients experience. By correcting this imbalance, more effective treatments could be devised.
